FindTrial
Sign In

Microbiome in Pulmonary Tuberculosis

Meta-genomic characterization of lung microbiome diversity and its alteration during anti-tubercular treatment in pulmonary tuberculosis - MLPTB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022504
Enrollment
272
Registered
2019-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 2: J988- Other specified respiratory disorders

Interventions

Control Intervention1: NIL: NIL

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Microbiologically confirmed pulmonary tuberculosis cases. 2. Participants with chronic cough.

Exclusion criteria

Exclusion criteria: 1. Old TB cases. 2.Pregnant and lactating women. 3.HIV confirmed cases.

Design outcomes

Primary

MeasureTime frame
Uncover the microbiome composition in Pulmonary tuberculosis and chronic obstructive pulmonary disorder casesTimepoint: Three years—

Secondary

MeasureTime frame
Understand the effect of anti-tubercular treatment on microbiome compositionTimepoint: Three years—

Countries

India

Contacts

Public ContactDr Kiran Chawla

Kasturba Medical College, Manipal

kiran.chawla@manipal.edu9980220484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026